Addiction and Crime Statistics 2026: Arrests, Incarceration, Drug Courts, and the New Hampshire and Massachusetts Numbers

Most of the addiction and crime statistics circulating online are recycled from federal reports that are 7 to 25 years old, often with the year quietly removed. That matters, because the real numbers have changed dramatically: drug arrests have fallen by nearly half since 2019, overdose deaths dropped almost 27 percent in a single year, and a body of new research now shows exactly which justice-system interventions reduce reoffending and death.

This guide rebuilds the addiction and crime picture from current primary sources only: the FBI's Crime Data Explorer, the Bureau of Justice Statistics' most recent national inmate survey, NHTSA, SAMHSA, NIDA, peer-reviewed cohort studies, and the state agencies of New Hampshire and Massachusetts. Every figure carries its source and data year, and a re-baseline table near the middle maps each commonly recycled stale statistic to its current replacement.

Key numbers at a glance

• Law enforcement reported 831,446 drug-related arrests in the United States in 2024 (FBI Crime Data Explorer, 2024 data released October 2025).
• 47 percent of state and federal prisoners met DSM-IV criteria for a substance use disorder in the 12 months before admission (BJS Survey of Prison Inmates 2016, published 2021).
• 38 percent of prisoners reported using drugs, and 30 percent reported drinking alcohol, at the time of their offense (BJS SPI 2016, published 2021).
• Only 33 percent of state prisoners with a substance use disorder participated in any treatment program since admission (BJS SPI 2016, published 2021).
• Roughly 60 percent of people who are incarcerated have a substance use disorder, per the National Institute on Drug Abuse (NIDA, updated 2024).
• 12,429 people died in alcohol-impaired driving crashes in 2023, 30 percent of all U.S. traffic deaths (NHTSA Traffic Safety Facts, 2023 data).
• In the first two weeks after release from prison, the risk of death is 12.7 times higher than the general population's (New England Journal of Medicine, 2007), and opioid overdose death risk has measured 40 times higher (American Journal of Public Health, 2018).
• Providing opioid use disorder medications in corrections cut post-release overdose deaths by 60.5 percent in Rhode Island (JAMA Psychiatry, 2018) and fatal overdoses by 52 percent across seven Massachusetts county jails (New England Journal of Medicine, 2025).
• More than 4,000 treatment courts operate in the United States (Office of Justice Programs / National Treatment Court Resource Center, accessed 2026).
• An estimated 107,400 veterans were serving time in state or federal prison (BJS SPI 2016, published 2021).
• 43 percent of state prisoners reported a history of a mental health problem (BJS SPI 2016, published 2021).
• New Hampshire recorded 287 confirmed overdose deaths in 2024, down about a third year over year (NH Office of the Chief Medical Examiner via NH DHHS Drug Monitoring Initiative, 2025), and Massachusetts recorded 978 opioid-related overdose deaths in 2025, the first time under 1,000 in more than a decade (Massachusetts DPH, June 2026).

Drug-related arrests in the United States: the 2023 and 2024 numbers

The arrest statistics most pages still cite come from the FBI's 2019 reporting year, before the agency completed its transition to the National Incident-Based Reporting System. The current numbers are much lower.

Arrest data reported to the FBI Crime Data Explorer show 831,446 drug-related arrests in 2024 (2024 data, released October 2025) and 870,874 drug arrests in 2023. In 2023, about 88 percent of those arrests were for possession (763,756) rather than sale or manufacturing (107,118). For scale, the FBI's 2019 tables reported more than 1.5 million arrests for drug abuse violations, so the pages still quoting 2019-era counts overstate today's enforcement volume by roughly 80 percent.

Two honest caveats belong next to any FBI arrest number, and almost no statistics page includes them. First, not every law enforcement agency reports arrest data to the FBI, so national totals are undercounts. Second, the shift from the older summary system to NIBRS changed category definitions, which makes precise year-over-year comparisons across the 2021 transition imperfect. Directionally, though, the trend is unambiguous: reported drug arrests are far below their late-2010s levels.

Substance use disorders among incarcerated people

The current national source on substance use among prisoners is the Bureau of Justice Statistics' Survey of Prison Inmates 2016, published in July 2021. It is based on face-to-face interviews with a national sample drawn from the roughly 1.42 million people then held in state and federal prisons, and it replaced the older 1997-2004 survey series that many websites still quote.

Its core findings (all BJS SPI 2016, published 2021):

• 47 percent of prisoners met DSM-IV criteria for a substance use disorder in the 12 months before admission, among those not incarcerated for that entire year: 49 percent of state and 32 percent of federal prisoners.
• 64 percent used at least one drug in the 30 days before their arrest (65 percent state, 53 percent federal).
• 38 percent were using drugs at the time of the offense (39 percent state, 31 percent federal), and 21 percent of state prisoners were using marijuana specifically.
• Among state prisoners at the time of the offense, 11 percent were using methamphetamine, 9 percent cocaine, 9 percent were misusing prescription drugs, and 5 percent were using heroin.

The National Institute on Drug Abuse, drawing on this and related research, puts it more simply on its criminal justice research page (updated 2024): roughly 60 percent of people who are incarcerated have a substance use disorder.

The treatment gap inside prisons is the statistic that should get the most attention. Among prisoners who met substance use disorder criteria, only 33 percent of state and 46 percent of federal prisoners had participated in any alcohol or drug treatment program since admission, and just 12 percent of state prisoners had received treatment in a residential unit (BJS SPI 2016, published 2021). For national context, SAMHSA's 2024 National Survey on Drug Use and Health (released 2025) estimates 48.4 million Americans age 12 and older, 16.8 percent, had a past-year substance use disorder.

Most of the people I have treated after incarceration were never treated during it. A sentence does not interrupt addiction; treatment does. The trajectory changes when care starts inside the walls and continues without a gap after release.

Dr. Richard Marasa, Medical Director, Clear Steps Recovery

Crime committed to get drugs or money for drugs

This is the most misquoted area in the entire topic. Claims that "30 to 40 percent of property crimes, 50 percent of burglaries, and 70 percent of robberies are committed for drug money" trace back to Bureau of Justice Statistics derivations of inmate surveys conducted between 1997 and 2004, published in a series BJS has explicitly marked as archived and no longer updates.

What the archived record actually said: in the 2004 survey, 17 percent of state and 18 percent of federal prisoners said they committed their offense to get money for drugs (BJS Drugs and Crime Facts, archived; 2004 data). BJS has not published an equivalent motive breakdown from the 2016 Survey of Prison Inmates, so there is currently no defensible "percent of burglaries committed for drug money" statistic. Anyone publishing one without a year is recycling the archived series.

The closest current measure is drug use at the time of the offense, by offense type: 55 percent of state prisoners sentenced for drug offenses, 49 percent sentenced for property offenses, and 35 percent sentenced for violent offenses reported using drugs at the time of the offense (BJS SPI 2016, published 2021).

Alcohol and crime

Alcohol's role in crime is usually described with a figure ("3 million violent crimes a year involve a drinking offender") that derives from a 1998 BJS Alcohol and Crime report built on mid-1990s victimization data, now archived. The current, dateable numbers look like this:

• 30 percent of prisoners reported drinking alcohol at the time of their offense, including 31 percent of state and 25 percent of federal prisoners (BJS SPI 2016, published 2021).
• Among state prisoners sentenced for violent offenses, 34 percent were drinking at the time of the offense, versus 24 percent for property and 22 percent for drug offenses (BJS SPI 2016, published 2021).
• In a nationally representative U.S. sample, about 29 percent of people who experienced intimate partner violence reported their partner had been drinking during those incidents (BMC Public Health, 2014, NESARC data).
• 12,429 people died in alcohol-impaired driving crashes in 2023, 30 percent of all traffic fatalities, one death every 42 minutes (NHTSA Traffic Safety Facts, 2023 data, published 2025). That is a 7.6 percent decrease from 2022, and it supersedes both the 10,511 figure (which is NHTSA's 2018 count) and the NHTSA 2016 numbers still circulating.

Drug types and crime: opioids, methamphetamine, and cocaine

The substances driving justice-system contact shifted over the past decade, and the deadliest risk now sits at the exit door of the jail, not inside it.

At the time of their offense, 11 percent of state prisoners were using methamphetamine, 9 percent cocaine, 9 percent misused prescription drugs, and 5 percent were using heroin; 20 percent of state prisoners had used heroin at some point in their lives (BJS SPI 2016, published 2021). Since that survey, illicitly manufactured fentanyl has displaced heroin in most U.S. drug markets, which is one reason post-release overdose has become the defining statistic of this topic.

The post-release overdose spike is one of the most replicated findings in addiction medicine:

• In Washington State, the risk of death in the first two weeks after release from prison was 12.7 times that of other state residents, with drug overdose the leading cause and a relative risk of 129 for overdose death specifically (New England Journal of Medicine, Binswanger et al., 2007).
• In North Carolina (2000 to 2015 releases), formerly incarcerated people faced opioid overdose death risk 40 times the general population's at two weeks post-release, and 74 times for heroin specifically (American Journal of Public Health, Ranapurwala et al., 2018).
• NIDA states plainly that overdose is the leading cause of death among people returning from jails and prisons (NIDA criminal justice topic, updated 2024).

The mechanism is clinical, not moral: tolerance falls during incarceration while the underlying opioid use disorder remains, so the same dose a person used before arrest can be fatal after release. That is why the medication data in the corrections section below matter so much.

For national context, CDC provisional data estimate 80,391 total U.S. overdose deaths in 2024, down 26.9 percent from 110,037 in 2023 (CDC National Center for Health Statistics, May 2025), with New Hampshire among the states posting declines of 35 percent or more.

What supersedes what: the re-baseline table

Every row below pairs a number still widely published on addiction and crime statistics pages with the current primary source that replaces it. If a page quotes the left column without a year, its data pipeline stopped years ago.

Drug courts and diversion: the numbers

Treatment courts divert people whose offenses are driven by substance use into supervised treatment instead of standard sentencing. More than 4,000 treatment courts now operate across the United States, and adult drug courts make up roughly half of them (Office of Justice Programs, citing the National Treatment Court Resource Center, accessed 2026).

Two federal evidence reviews anchor the outcome data:

• The National Institute of Justice's Multisite Adult Drug Court Evaluation found 40 percent of drug court participants reported committing a crime in the prior year versus 53 percent of comparable non-participants, and 56 percent reported drug use versus 76 percent (NIJ MADCE, reported by OJP).
• The U.S. Government Accountability Office reviewed evaluations covering 32 drug court programs and found participants' rearrest rates were 6 to 26 percentage points lower than comparison groups', with statistically significant differences in 18 programs (GAO-12-53, 2011).

Two things are worth stating carefully. Drug courts are voluntary, eligibility is limited, and admission and graduation decisions belong entirely to the court. And participation typically requires engaging with licensed community treatment, which is where outpatient providers fit into the picture: as the treatment arm the court supervises, not as a legal actor.

Veterans, justice involvement, and veterans treatment courts

An estimated 107,400 veterans were serving time in state or federal prison in the 2016 national survey, 98 percent of them male (BJS, Veterans in Prison: Survey of Prison Inmates 2016, published 2021). Veterans in state prison were more likely than non-veterans to be serving time for violent offenses and less likely to be serving for drug offenses (9 percent versus 15 percent).

Veterans treatment courts adapt the drug court model with veteran peer mentors and VA care coordination, and they operate as part of the specialty court systems in both Massachusetts and New Hampshire (Mass.gov specialty courts; NH Judicial Branch). For veterans dealing with substance use, court-connected or not, VA benefits can fund community care; we cover how that works in our guide to veterans addiction treatment through VA Community Care, and Clear Steps Recovery runs a dedicated VA rehab program under that framework.

Dual diagnosis among justice-involved people

Substance use disorders rarely travel alone through the justice system. In the same national survey, 43 percent of state and 23 percent of federal prisoners reported a history of a mental health problem, and 14 percent of state prisoners met the threshold for serious psychological distress in the past 30 days (BJS, Indicators of Mental Health Problems Reported by Prisoners: SPI 2016, published 2021). Major depressive disorder was the most commonly reported condition, at 27 percent of state prisoners.

Overlap these figures with the 47 percent substance use disorder prevalence from the same survey and the picture is clear: a large share of the prison population is managing both conditions at once, which is exactly the population least served by single-track programs. We explain how integrated care works in our guide to dual diagnosis treatment for depression, anxiety, and addiction.

In practice, the revolving door is usually untreated illness, not moral failure. When depression, trauma, or another psychiatric condition sits underneath a substance use disorder, treating one and ignoring the other rarely holds. Care has to be designed for both conditions at once, and it has to keep going after the court date.

Dr. Richard Marasa, Medical Director, Clear Steps Recovery

Medication-assisted treatment in jails and prisons

The strongest evidence in this entire topic concerns medications for opioid use disorder (methadone, buprenorphine, and naltrexone) provided during incarceration:

• Rhode Island became the first state to screen and treat with all three medications across its unified correctional system, and post-incarceration overdose deaths fell 60.5 percent in the year after implementation (JAMA Psychiatry, Green et al., 2018).
• Across seven Massachusetts county jails, people who received these medications in jail were far more likely to engage community treatment within 30 days of release (60.2 percent versus 17.6 percent), had a 52 percent lower rate of fatal overdose, 56 percent lower all-cause mortality, and 12 percent lower reincarceration (New England Journal of Medicine, 2025).
• A meta-analysis of prison and jail programs found methadone during incarceration increased post-release treatment engagement and reduced illicit opioid and injection use; effects on reoffending strengthen when medication continues after release (Journal of Substance Abuse Treatment, Moore et al., 2019).
• A NIDA-funded modeling analysis estimated that treating opioid use disorder with medication while people are detained could reduce overdose deaths by 31 percent, yet fewer than half of jails and fewer than 10 percent of state prisons provide access to all three medications (NIDA criminal justice topic, updated 2024).

The live policy story in northern New England runs ahead of the national curve. Massachusetts' Chapter 208 of the Acts of 2018 (Massachusetts General Court) made it the first state to mandate that county correctional facilities deliver all three FDA-approved medications, initially at five houses of correction with two more joining voluntarily; the 2025 NEJM results above are that mandate's measured outcome. New Hampshire's Department of Corrections makes medication-assisted treatment available to residents at all of its facilities, with case management that follows people for up to a year after release (NH DOC services, accessed 2026).

Continuity is the entire game: the medication started inside only protects people if a community provider continues it. That is the role outpatient medication-assisted treatment in New Hampshire and MAT in Massachusetts programs play in the reentry chain.

For opioid use disorder, medication combined with structured outpatient care is the strongest evidence-based tool we have, and the days right after release are exactly when it matters most. Tolerance falls during incarceration while the illness does not, so a person walks out at their most medically vulnerable moment. Starting medication before that door opens, and continuing it in the community, is basic, life-saving continuity of care.

Dr. Richard Marasa, Medical Director, Clear Steps Recovery

Recidivism and treatment: what actually reduces reoffending

Strip away the undated citations and the current evidence sorts by intervention:

• Medications for opioid use disorder during incarceration: 12 percent lower reincarceration in the Massachusetts jail cohort (NEJM, 2025), with meta-analytic evidence that recidivism benefits depend on continuing medication after release (J Subst Abuse Treat, 2019).
• Drug courts: rearrest rates 6 to 26 percentage points lower (GAO-12-53, 2011); less self-reported crime and drug use (NIJ MADCE).
• Treatment continuity after release: the Massachusetts cohort's 60.2 percent versus 17.6 percent community treatment engagement gap (NEJM, 2025) is the mechanism behind both the mortality and reoffending differences.

The honest limitation: no treatment eliminates reoffending or relapse, and programs that account for post-release engagement show stronger effects than those that stop measuring at the gate. Relapse itself follows chronic-illness patterns rather than moral ones, a point we unpack with data in our relapse statistics guide.

New Hampshire and Massachusetts: the state justice-system numbers

No national statistics page publishes a state-level picture for northern New England. Here is the compiled current record, from state primary sources.

Both states' overdose declines outpaced the national trend: CDC provisional data placed New Hampshire among states with declines of 35 percent or more in 2024 (CDC NCHS, May 2025), and Massachusetts' 2025 total sits nearly 60 percent below its 2022 record high of 2,364 deaths (Mass.gov, June 2026). The New Hampshire Drug Monitoring Initiative publishes the underlying monthly numbers on the NH DHHS substance misuse data page, Massachusetts DPH maintains its running counts on the current opioid statistics page, and the Massachusetts Trial Court documents the recovery court system.

From the justice system to treatment

For a person leaving a courtroom or a correctional facility, the statistics above compress into one practical fact: the highest-risk window is the first weeks back in the community, and structured, evidence-based outpatient care during that window is what changes the numbers.

What that looks like in practice, whether a court is supervising it or a family arranged it, is a matched level of care: an intensive outpatient program or day treatment for people who need structure while living at home, medication for opioid or alcohol use disorder where clinically indicated, integrated mental health treatment for co-occurring conditions, and telehealth options that remove the transportation barriers that derail many reentry plans. Clear Steps Recovery provides these outpatient levels of care for adults in Londonderry, New Hampshire and Needham, Massachusetts; we are a treatment provider, not part of the court system, and no provider can promise a particular legal outcome. Courts decide diversion and sentencing questions; what treatment changes, per the evidence above, is health, mortality risk, and the likelihood of coming back.

About the numbers in this article: methodology and sourcing

Every statistic above is drawn from a primary source: federal agencies (FBI, BJS, NHTSA, SAMHSA, NIDA, CDC, GAO, OJP), state agencies (NH Judicial Branch, NH DHHS, NH DOC, Massachusetts Trial Court, MA DPH, the Massachusetts General Court), and peer-reviewed journals (NEJM, JAMA Psychiatry, AJPH, Journal of Substance Abuse Treatment, BMC Public Health). Each figure carries its data year and publication year inline, because several of the most cited numbers in this field come from surveys conducted decades ago. Where a widely quoted statistic has no current published equivalent (such as the share of burglaries committed for drug money), we say so rather than substituting an approximation. Arrest figures reflect what agencies reported to the FBI and are undercounts; state overdose figures for the most recent year include medical examiner cases pending finalization and may be revised. This article was last reviewed on July 3, 2026, and we update it as new federal and state releases publish.